Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schreiner MediPharm is the healthcare-focused business unit of Schreiner Group, a German family-owned high-tech label manufacturer. The business develops and produces multifunctional specialty labels and self-adhesive marking solutions for the pharmaceutical industry, medical technology, and clinical trials. Its products are designed to improve product and patient safety, enable traceability and authentication, support digital adherence and connectivity, and simplify medication dispensing and administration. Core offerings include pharmaceutical labels with integrated functional features such as RFID, NFC, tamper evidence, needle-trap safety elements, and detachable documentation parts. Rather than a drug developer, Schreiner MediPharm operates as a commercial supplier and development partner to pharma and medical device companies worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schreiner MediPharm.